Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$772.82
-1.0%
$773.61
$677.09
$972.53
$732.43B0.43.66 million shs2.57 million shs
Tesla, Inc. stock logo
TSLA
Tesla
$293.94
-6.8%
$320.93
$182.00
$488.54
$946.77B2.39101.04 million shs130.20 million shs
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
0.00%+0.44%+1.25%+7.97%-14.76%
Tesla, Inc. stock logo
TSLA
Tesla
0.00%-3.11%+6.24%+34.41%+24.67%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
4.9861 of 5 stars
4.44.03.34.03.01.71.9
Tesla, Inc. stock logo
TSLA
Tesla
4.4867 of 5 stars
2.13.00.03.53.05.01.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2.75
Moderate Buy$1,011.6130.90% Upside
Tesla, Inc. stock logo
TSLA
Tesla
2.24
Hold$301.602.60% Upside

Current Analyst Ratings Breakdown

Latest LLY and TSLA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/7/2025
Tesla, Inc. stock logo
TSLA
Tesla
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
7/3/2025
Tesla, Inc. stock logo
TSLA
Tesla
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$285.00 ➝ $315.00
7/3/2025
Tesla, Inc. stock logo
TSLA
Tesla
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingReduce ➝ Reduce$120.00
7/1/2025
Tesla, Inc. stock logo
TSLA
Tesla
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$500.00
6/30/2025
Tesla, Inc. stock logo
TSLA
Tesla
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$290.00
6/30/2025
Tesla, Inc. stock logo
TSLA
Tesla
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$303.00
6/26/2025
Tesla, Inc. stock logo
TSLA
Tesla
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$350.00 ➝ $475.00
6/23/2025
Tesla, Inc. stock logo
TSLA
Tesla
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSell ➝ Sell$190.00 ➝ $215.00
6/23/2025
Tesla, Inc. stock logo
TSLA
Tesla
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSell ➝ Sell$175.00
6/20/2025
Tesla, Inc. stock logo
TSLA
Tesla
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral
6/20/2025
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$936.00
(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$45.04B16.26$14.09 per share54.84$15.03 per share51.42
Tesla, Inc. stock logo
TSLA
Tesla
$95.72B9.89$3.61 per share81.41$22.89 per share12.84
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$10.59B$12.2962.8824.831.1422.67%85.51%15.74%8/7/2025 (Estimated)
Tesla, Inc. stock logo
TSLA
Tesla
$7.13B$1.82161.5186.719.176.66%9.02%5.39%7/22/2025 (Estimated)

Latest LLY and TSLA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/22/2025Q2 2025
Tesla, Inc. stock logo
TSLA
Tesla
$0.43N/AN/AN/A$23.18 billionN/A
5/1/2025Q1 2025
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$4.64$3.34-$1.30$3.06$12.77 billion$12.73 billion
4/22/2025Q1 2025
Tesla, Inc. stock logo
TSLA
Tesla
$0.53$0.27-$0.26$0.12$22.93 billion$19.34 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$6.000.78%N/A48.82%11 Years
Tesla, Inc. stock logo
TSLA
Tesla
N/AN/AN/AN/AN/A

Latest LLY and TSLA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/23/2025
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
quarterly$1.500.78%8/15/20258/15/20259/10/2025
5/5/2025
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
quarterly$1.500.73%5/16/20255/16/20256/10/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2.18
1.37
1.06
Tesla, Inc. stock logo
TSLA
Tesla
0.07
2.00
1.54

Institutional Ownership

CompanyInstitutional Ownership
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
82.53%
Tesla, Inc. stock logo
TSLA
Tesla
66.20%

Insider Ownership

CompanyInsider Ownership
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
0.14%
Tesla, Inc. stock logo
TSLA
Tesla
20.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
47,000947.74 million946.41 millionOptionable
Tesla, Inc. stock logo
TSLA
Tesla
125,6653.22 billion2.55 billionOptionable

Recent News About These Companies

Top Utility Stocks To Consider - July 7th
Solar Stocks To Follow Now - July 7th
Retail Stocks Worth Watching - July 7th
Industrial Stocks To Watch Now - July 7th
Energy Stocks Worth Watching - July 7th
Options Bears Cheer Another Tesla Stock Setback
Tesla Stock Breakdown: Why Another 20% Drop is Next

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Eli Lilly and Company stock logo

Eli Lilly and Company NYSE:LLY

$772.82 -7.85 (-1.01%)
As of 03:59 PM Eastern

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Tesla stock logo

Tesla NASDAQ:TSLA

$293.94 -21.41 (-6.79%)
As of 04:00 PM Eastern

Tesla, Inc. designs, develops, manufactures, leases, and sells electric vehicles, and energy generation and storage systems in the United States, China, and internationally. The company operates in two segments, Automotive, and Energy Generation and Storage. The Automotive segment offers electric vehicles, as well as sells automotive regulatory credits; and non-warranty after-sales vehicle, used vehicles, body shop and parts, supercharging, retail merchandise, and vehicle insurance services. This segment also provides sedans and sport utility vehicles through direct and used vehicle sales, a network of Tesla Superchargers, and in-app upgrades; purchase financing and leasing services; services for electric vehicles through its company-owned service locations and Tesla mobile service technicians; and vehicle limited warranties and extended service plans. The Energy Generation and Storage segment engages in the design, manufacture, installation, sale, and leasing of solar energy generation and energy storage products, and related services to residential, commercial, and industrial customers and utilities through its website, stores, and galleries, as well as through a network of channel partners; and provision of service and repairs to its energy product customers, including under warranty, as well as various financing options to its solar customers. The company was formerly known as Tesla Motors, Inc. and changed its name to Tesla, Inc. in February 2017. Tesla, Inc. was incorporated in 2003 and is headquartered in Austin, Texas.